S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NASDAQ:IMGO

Imago BioSciences Stock Forecast, Price & News

$19.56
+0.65 (+3.44 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.90
$19.89
50-Day Range
$16.00
$28.84
52-Week Range
$14.99
$35.68
Volume215,957 shs
Average Volume158,517 shs
Market Capitalization$653.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IMGO News and Ratings via Email

Sign-up to receive the latest news and ratings for Imago BioSciences and its competitors with MarketBeat's FREE daily newsletter.


Imago BioSciences logo

About Imago BioSciences

Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif.

Headlines

Imago BioSciences (NASDAQ:IMGO) Shares Gap Down to $18.91
Imago BioSciences (NASDAQ:IMGO) Shares Gap Down to $18.91
September 24, 2021 |  americanbankingnews.com
Imago BioSciences (NASDAQ:IMGO) Trading Down 5%
Imago BioSciences (NASDAQ:IMGO) Trading Down 5%
September 23, 2021 |  americanbankingnews.com
Imago BioSciences (NASDAQ:IMGO) Trading Up 7.7%
Imago BioSciences (NASDAQ:IMGO) Trading Up 7.7%
September 21, 2021 |  americanbankingnews.com
Imago BioSciences (NASDAQ:IMGO) Stock Price Down 7.2%
Imago BioSciences (NASDAQ:IMGO) Stock Price Down 7.2%
September 16, 2021 |  americanbankingnews.com
Imago Biosciences Inc
Imago Biosciences Inc
September 14, 2021 |  reuters.com
Imago BioSciences (NASDAQ:IMGO) Trading 8.2% Higher
Imago BioSciences (NASDAQ:IMGO) Trading 8.2% Higher
September 14, 2021 |  americanbankingnews.com
Imago BioSciences (NASDAQ:IMGO) Shares Gap Up to $24.98
Imago BioSciences (NASDAQ:IMGO) Shares Gap Up to $24.98
September 9, 2021 |  americanbankingnews.com
Imago BioSciences (NASDAQ:IMGO) Shares Up 9.5%
Imago BioSciences (NASDAQ:IMGO) Shares Up 9.5%
September 8, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

754th out of 1,351 stocks

Pharmaceutical Preparations Industry

369th out of 664 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Imago BioSciences (NASDAQ:IMGO) Frequently Asked Questions

Is Imago BioSciences a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Imago BioSciences in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Imago BioSciences stock.
View analyst ratings for Imago BioSciences
or view top-rated stocks.

What stocks does MarketBeat like better than Imago BioSciences?

Wall Street analysts have given Imago BioSciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Imago BioSciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Imago BioSciences' next earnings date?

Imago BioSciences is scheduled to release its next quarterly earnings announcement on Thursday, November 18th 2021.
View our earnings forecast for Imago BioSciences
.

How were Imago BioSciences' earnings last quarter?

Imago BioSciences Inc (NASDAQ:IMGO) released its quarterly earnings data on Wednesday, August, 18th. The company reported ($8.13) EPS for the quarter, missing analysts' consensus estimates of ($0.33) by $7.80.
View Imago BioSciences' earnings history
.

What price target have analysts set for IMGO?

4 brokerages have issued twelve-month price targets for Imago BioSciences' stock. Their forecasts range from $30.00 to $35.00. On average, they anticipate Imago BioSciences' share price to reach $32.00 in the next year. This suggests a possible upside of 63.6% from the stock's current price.
View analysts' price targets for Imago BioSciences
or view top-rated stocks among Wall Street analysts.

When did Imago BioSciences IPO?

(IMGO) raised $105 million in an initial public offering (IPO) on Friday, July 16th 2021. The company issued 7,000,000 shares at $14.00-$16.00 per share.

What is Imago BioSciences' stock symbol?

Imago BioSciences trades on the NASDAQ under the ticker symbol "IMGO."

When did Imago BioSciences' quiet period expire?

Imago BioSciences' quiet period expired on Wednesday, August 25th. Imago BioSciences had issued 8,400,000 shares in its IPO on July 16th. The total size of the offering was $134,400,000 based on an initial share price of $16.00. During Imago BioSciences' quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Imago BioSciences?

Shares of IMGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Imago BioSciences' stock price today?

One share of IMGO stock can currently be purchased for approximately $19.56.

How much money does Imago BioSciences make?

Imago BioSciences has a market capitalization of $653.95 million.

How many employees does Imago BioSciences have?

Imago BioSciences employs 2,021 workers across the globe.

What is Imago BioSciences' official website?

The official website for Imago BioSciences is www.imagobio.com.

Where are Imago BioSciences' headquarters?

How can I contact Imago BioSciences?

Imago BioSciences' mailing address is 329 OYSTER POINT BLVD. 3RD FLOOR, SOUTH SAN FRANCISCO CA, 904080. The company can be reached via phone at 415-529-5055.


This page was last updated on 9/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.